Access to medicines and high-quality therapeutics: global responsibilities for clinical pharmacology

Richard O Day, Donald J Birkett, John Miners, David A Henry, Gillian M Shenfield and J Paul Seale
Med J Aust 2005; 182 (7): . || doi: 10.5694/j.1326-5377.2005.tb06728.x
Published online: 4 April 2005

A major theme of the 2004 World Congress of Clinical Pharmacology and Therapeutics was worldwide equity of access to medicines

The 8th World Congress of Clinical Pharmacology and Therapeutics was held in Brisbane in August 2004. There were 940 participants from 60 countries, with Japan, Germany, Korea, South Asia and the United Kingdom well represented. The Congress featured three themes: Medicines and Society; Therapeutic Horizons; and Drug Discovery, Development and Disposition. Our report focuses on the Medicines and Society theme, which was strongly emphasised at the 8th Congress, differentiating it from previous Congresses. The prominence of this theme was to encourage the participation of clinical pharmacologists from South Asia and the Pacific regions, where access to lifesaving medicines and confidence in their quality are matters of everyday importance. The Congress also sought to encourage clinical pharmacologists from the developed world to engage with the serious global inequities in access to medicines for the major infectious diseases in the developing world, such as tuberculosis, malaria and HIV/AIDs, as well as the emerging developed-world lifestyle disorders, notably cardiovascular disease.

  • Richard O Day1
  • Donald J Birkett2
  • John Miners3
  • David A Henry4
  • Gillian M Shenfield5
  • J Paul Seale6

  • 1 St Vincent’s Hospital, Sydney, NSW.
  • 2 Johnson & Johnson Research Pty Ltd, Sydney NSW.
  • 3 Flinders University, Adelaide, SA.
  • 4 Mater Hospital, Newcastle, NSW.
  • 5 Royal North Shore Hospital, Sydney, NSW.
  • 6 University of Sydney, Sydney, NSW.


Competing interests:

None identified.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.